Josée Zijlstra-Baalbergen

PROF.DR., (Principal Investigator)

20022024

Research activity per year

Network

Julia Driessen

Person: Academic

C.M. Eeltink

Person: Administrative

Paul Lips

Person: Academic

Dieta Brandsma

Person: Academic

Nik Sol

Person: Academic

Tuna Mutis

Person: Academic

Inger Nijhof

Person: Academic

Kevin Mol

Person: Academic

Suzanne Neppelenbroek

Person: Academic

Chris Dickhoff

Person: Academic

Ka-Hoo Lam

Person: Academic

Mujde Durmaz

Person: Academic

Ellis Barbé

Person: Academic

Laura Meijer

Person: Academic

Myron Best

Person: Academic

Mafalda Antunes Ferreira

Person: Academic

Markus Schweiger

Person: Academic

Florent Moulière

Person: Academic

Pieternella J. Lugtenburg

  • Erasmus MC University Medical Center Rotterdam
  • Erasmus Universiteit Rotterdam

External person

Peter Borchmann

  • University of Cologne

External person

Andreas Engert

  • University of Cologne

External person

Richard Greil

  • Landeskliniken Betriebsges. MbH
  • Paracelsus Private Medical University
  • Salzburg Cancer Research Institute
  • Cancer Cluster Salzburg
  • Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT)

External person

Michael Fuchs

  • University of Cologne

External person

Carsten Kobe

  • University of Cologne
  • VU Medisch Centrum

External person

Max S. Topp

  • University of Würzburg

External person

Markus Dietlein

  • University of Cologne

External person

Christian Baues

  • University of Cologne

External person

Julia Meissner

  • Heidelberg University

External person

Simone Pieplenbosch

  • Department of Hematology, 1081 HV Amsterdam, Netherlands
  • Department of Radiology & Nuclear Medicine, Amsterdam, Netherlands
  • Vrije Universiteit Amsterdam

External person

Volker Diehl

  • University of Cologne

External person

Hans Eich

  • University of Münster

External person

Bastian von Tresckow

  • University Hospital of Cologne
  • University of Cologne
  • University of Duisburg-Essen

External person

Jana Markova

  • Charles University

External person

N. George Mikhaeel

  • VU Medisch Centrum

External person

Helen Goergen

  • University of Cologne

External person

Marcel Nijland

  • Department of Hematology, United States
  • University of Groningen

External person

Cécile P.M. Janus

  • Erasmus University MC Cancer Institute
  • Erasmus MC
  • Erasmus Universiteit Rotterdam

External person

Sally F Barrington

  • VU Medisch Centrum
  • & King's Health Partners Comprehensive Cancer Centre

External person

Dennis A. Eichenauer

  • University of Cologne

External person

Richard W.M. van der Maazen

  • Radboud University Medical Center

External person

Ulrich Dührsen

  • VU Medisch Centrum
  • University of Duisburg-Essen

External person

Martin Soekler

  • University of Tübingen

External person

Michael Schaapveld

  • Netherlands Cancer Institute
  • Netherlands Comprehensive Cancer Organisation (IKNL)

External person

Harald Stein

  • Berlin Reference Center for Lymphoma and Haematopathology

External person

Andreas Rosenwald

  • University of Würzburg

External person

Catherine Thieblemont

  • Université Paris Cité

External person

Johannes S.P. Vermaat

  • Utrecht University
  • Department of Haematology
  • Leiden University

External person

Georg Kuhnert

  • University of Cologne

External person

Ulrich Bernd Keller

  • Technical University of Munich

External person

Thomas Pabst

  • University of Bern
  • Swiss Group for Clinical Cancer Research and Cantonal Hospital Lucerne
  • Institute of Medical Oncology

External person

Bernd Hertenstein

  • Klinikum Bremen Mitte

External person

Lara H. Böhmer

  • Haga Ziekenhuis

External person

Jeanette K. Doorduijn

  • Erasmus MC Cancer Institute
  • Erasmus Universiteit Rotterdam

External person

Elisabeth Pfaehler

  • University Medical Center Groningen
  • University of Groningen

External person

Martin Vogelhuber

  • University of Regensburg

External person

Stephanie Sasse

  • University of Cologne

External person

Andreas Hüttmann

  • University of Duisburg-Essen

External person

Anne I J Arens

  • Radboud University Nijmegen

External person

Bronno van der Holt

  • Erasmus Universiteit Rotterdam

External person

Katerina Bakunina

  • Erasmus Universiteit Rotterdam

External person

Augustinus Dg Krol

  • Leiden University Medical Centre

External person

Paul J. Bröckelmann

  • University of Cologne

External person

Jakoba J. Eertink

  • Vrije Universiteit Amsterdam

External person

Avinash G. Dinmohamed

  • Erasmus University Medical Center
  • Netherlands Comprehensive Cancer Organisation (IKNL)
  • Vrije Universiteit Amsterdam
  • University of Amsterdam
  • Department of Research
  • Erasmus Universiteit Rotterdam
  • Department of Research and Development
  • Research and Development Department

External person

Gustaaf W van Imhoff

  • University Medical Center Groningen
  • University of Groningen

External person

Monique A. J. van Eijndhoven

  • Vrije Universiteit Amsterdam
  • Netherlands C. Inst./A. van L. Hosp.

External person

Martin Wilhelm

  • Klinikum Nurnberg

External person

Anna M. van Eggermond

  • Netherlands Cancer Institute

External person

Fátima De la Cruz

  • Hospital Universitario Virgen del Rocio

External person

Berthe M. P. Aleman

  • Antoni Van Leeuwenhoek

External person

Sylvain Choquet

  • Sorbonne Université

External person

Federica Cavallo

  • University of Turin

External person

Michael Schuster

  • Austrian Academy of Sciences
  • Johannes Gutenberg University Mainz
  • Stony Brook University

External person

Tom Vieler

  • Kiel University

External person

Koop Bosscha

  • Jeroen Bosch Ziekenhuis

External person

Felicitas Hitz

  • Swiss Group for Clinical Cancer Research and Cantonal Hospital Lucerne
  • Cantonal Hospital St. Gallen

External person

Sameer Bakhshi

  • All India Institute of Medical Sciences, New Delhi

External person

Martin Bentz

  • Staedtisches Klinikum Karlsruhe

External person

Marie Maerevoet

  • Université libre de Bruxelles

External person

Karen Holtmaat

  • VU University
  • Amsterdam UMC

External person

Krzysztof Warzocha

  • Institute of Hematology and Blood Transfusion

External person

Gustaaf W. van Imhoff

  • University of Groningen

External person

Miguel A. Canales

  • Universidad Autónoma de Madrid

External person

Nada Hamad

  • St. Vincent's Hospital Sydney

External person

Harm Van Tinteren

  • Netherlands Cancer Institute
  • Comprehensive Cancer Centre the Netherlands
  • Antoni Van Leeuwenhoek Hospital
  • KU Leuven

External person

Rolf E. Brouwer

  • Diagnostic Center RDGG
  • Reinier de Graaff Gasthuis
  • Reinier de Graaf Groep
  • Dept. Hematol., (R.E.B., M.v.d.H.

External person

Annette Plütschow

  • University Hospital of Cologne
  • University of Cologne

External person

Anne-S. golène Cottereau

  • Université Paris-Saclay
  • Université Paris Cité

External person

Adrienne H. Brouwers

  • University Medical Center Groningen
  • University Medical Center Groningen, Centre for Revalidation (Beatrix Children's Hospital)
  • Afdeling Nucleaire Geneeskunde en Moleculaire beeldvorming
  • University of Groningen
  • Department of Obstetrics and Gynaecology

External person

Brian Hill

  • Cleveland Clinic Foundation

External person

Julia Thiemer

  • University of Marburg

External person

Michael Hallek

  • University of Cologne

External person

Alden Moccia

  • Università della Svizzera italiana
  • Swiss Group for Clinical Cancer Research and Cantonal Hospital Lucerne

External person

Andreas Viardot

  • Ulm University

External person

N. L. Tiren-Verbeet

  • Erasmus University Medical Centre

External person

Juan Manuel Sancho

  • Autonomous University of Barcelona

External person

Fritz Offner

  • Ghent University

External person

G. A.P. Nieuwenhuijzen

  • Catharina Hospital

External person

Rob Fijnheer

  • Utrecht University

External person

Helmut Ostermann

  • Ludwig Maximilian University of Munich

External person

Martin Hutchings

  • University of Copenhagen

External person

R. J.E. Sedee

  • Department of Otorhinolaryngology
  • Haaglanden MC

External person

K. Bosscha

  • Jeroen Bosch Hospital

External person

Elisabeth A G Pfaehler

  • University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands; Netherlands Heart Institute, Utrecht, The Netherlands; University of Groningen, University Medical Center Groningen, Department of Clinical and Experimental Cardiology, Groningen, The Netherlands; University of Groningen, University Medical Center Groningen, Department of Pathology, Groningen, The Netherlands. Electronic address: w.p.te.rijdt@umcg.nl.

External person

T. Vassilakopoulos

  • Laiko Hospital
  • National and Kapodistrian University of Athens

External person

J. Honings

  • Donders Institute

External person

Judith Roesink

  • Utrecht University

External person

Jan Pruim

  • University of Groningen
  • Stellenbosch University
  • University Medical Center Groningen
  • Vrije Universiteit Amsterdam

External person

Stefanie Kreissl

  • University of Cologne

External person

Miklos Egyed

  • Teaching Hospital Mór Kaposi

External person

Stefan W Krause

  • Friedrich-Alexander University Erlangen-Nürnberg

External person

Wouter J. Plattel

  • University of Groningen

External person

Yavuz M. Bilgin

  • Department of Haematology, Goes, Netherlands
  • Admiraal de Ruijter Hospital Goes
  • Admiraal de Ruijter Hospital

External person

L. van de Poll-Franse

  • Netherlands Comprehensive Cancer Organisation
  • Department of Pathology
  • Tilburg University
  • Research Department

External person

Annemieke W.J. Opstal-van Winden

  • Netherlands Cancer Institute

External person

Nagesh Kalakonda

  • University of Liverpool

External person

George Follows

  • Addenbrooke's Hospital

External person

Kelly Corona

  • Karyopharm Therapeutics

External person

R.P. Takes

  • Donders Institute
  • Radboud University Nijmegen

External person

Yvonne W.S. Jauw

  • Vrije Universiteit Amsterdam

External person

Bart de Keizer

  • Utrecht University

External person

Berthe M P Aleman

  • Netherlands Cancer Institute

External person

C. G. Schaar

  • Gelre ziekenhuis

External person

Ronit Gurion

  • Rabin Medical Center Israel
  • Tel Aviv University

External person

J.A. Hardillo

  • Erasmus University Medical Centre

External person

Georg Maschmeyer

  • Ernst von Bergmann Hospital
  • Klinikum Ernst von Bergmann

External person

Eduardus F.M. Posthuma

  • Reinier de Graaf Groep
  • Leiden University

External person

Christine Hanoun

  • University of Duisburg-Essen

External person

R.J. Baatenburg de Jong

  • Erasmus MC Cancer Institute
  • Erasmus University Medical Centre
  • Erasmus MC

External person

Stefan Müller

  • VU Medisch Centrum
  • University of Duisburg-Essen

External person

Andre Goy

  • Rutgers - The State University of New Jersey, Newark

External person

Sven Borchmann

  • Universität zu Köln
  • German Hodgkin Study Group

External person

R. Carr

  • Guy’s Hospital
  • South Warwickshire NHS Foundation Trust

External person

Jatin Shah

  • Karyopharm Therapeutics

External person

Walter Aulitzky

  • Robert Bosch Foundation

External person

Lothar Kanz

  • University of Tübingen

External person

I. Houtenbos

  • Spaarne Gasthuis

External person

Maria C. Ferrández

  • Vrije Universiteit Amsterdam

External person

Caroline Mandigers

  • Canisius Wilhelmina Hospital

External person

Norbert Schmitz

  • Asklepios Klinik St. Georg
  • University of Münster

External person

Ulrich Jäger

  • Department of Medicine i, Vienna, Austria

External person

Marca H M Wauben

  • Utrecht University

External person

Rene-Olivier Casasnovas

  • Hôpital du Bocage, CHU Dijon Bourgogne

External person

Karolin Behringer

  • University Hospital of Cologne

External person

Sandra van Dulmen

  • Netherlands Institute for Health Services Research
  • Radboud University Nijmegen
  • University of South-Eastern Norway

External person

Rogier Mous

  • Utrecht University
  • Sanquin Blood Supply Foundation

External person

Andreas Lohri

  • Cantonal Hospital Baselland
  • Swiss Group for Clinical Cancer Research and Cantonal Hospital Lucerne

External person

R. S. van Rijn

  • Medical Centre Leeuwarden

External person

H.T. Eich

  • Max Planck Institute for Plasma Physics

External person

Wolfgang Willenbacher

  • Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT)
  • Innsbruck Medical University
  • Oncotyrol

External person

Eric W. van den Neste

  • Université catholique de Louvain

External person

Robert P. Takes

  • Radboud University Nijmegen Medical Center
  • Radboud University Nijmegen

External person

Anne Sophie Jacob

  • Universität zu Köln

External person

Antoon T M Willemsen

  • University of Groningen, University Medical Center Groningen
  • University Medical Center Groningen
  • University of Groningen

External person

Simone Pieplenbosch

  • Amsterdam UMC
  • Vrije Universiteit Amsterdam

External person

R. Nieuwland

  • Academic Medical Center
  • University of Amsterdam

External person

L. Ceriani

  • Department of Nuclear Medicine and PET/CT Centre, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland;
  • Swiss Group for Clinical Cancer Research

External person

Sandra A. W. M. Verkuijlen

  • VU University Medical Center
  • Vrije Universiteit Amsterdam

External person

Zdenek Král

  • Masaryk University

External person

Lara H Bohmer

  • Department of Internal Medicine, Netherlands

External person

Michel van Gelder

  • Maastricht University

External person

Boris Böll

  • University Hospital of Cologne

External person

Wim J. G. Oyen

  • Radboud University Nijmegen
  • Institute of Cancer Research
  • European Organisation for Research and Treatment of Cancer Data Center
  • Radboud University Medical Center
  • Royal Marsden NHS Foundation Trust
  • Department of Obstetrics and Gynaecology

External person

T. Györke

  • Semmelweis University

External person

Craig H. Moskowitz

  • University of Miami

External person

Alison J. Moskowitz

  • Memorial Sloan Kettering Cancer Center

External person

Wolfgang A. Weber

  • University of Oxford
  • Rutherford Appleton Laboratory

External person

Priyanka Samal

  • Siksha ‘O’ Anusandhan University

External person

Inge M. Krul

  • Netherlands Cancer Institute

External person

Wolf Dieter Ludwig

  • HELIOS Medical Center Berlin-Buch

External person

S. Czibor

  • Semmelweis University

External person

Ina Buehnen

  • University of Cologne

External person

Bertjan Arends

  • Catharina Hospital

External person

Jakoba J. Eertink

  • Vrije Universiteit Amsterdam

External person

Matthew Ku

  • Simons Foundation

External person

Lara Böhmer

  • Haga Ziekenhuis

External person

Irène Buvat

  • Université Paris-Saclay

External person

Marie L. de Bruin

  • Utrecht University
  • Medicines Evaluation Board

External person

Liane te Boome

  • Haaglanden Medisch Centrum

External person

Eric P Visser

  • Department of Obstetrics and Gynaecology

External person

Franck Morschhauser

  • Centre Hospitalier Universitaire

External person

Marianne Just

  • Onkologische Schwerpunktpraxis Bielefeld

External person

Jan Paul de Boer

  • Netherlands Cancer Institute

External person

W.T. van den Broek

  • St. Anna Hospital

External person

Monique E. van Leerdam

  • Antoni Van Leeuwenhoek Hospital
  • Netherlands Cancer Institute
  • Leiden University

External person

Paolo Caimi

  • Case Western Reserve University

External person

Julia Huijbregts

  • Gelre Ziekenhuizen

External person

Michael Pfreundschuh

  • Saarland University

External person

Dagmar Kühnhardt

  • Charité – Universitätsmedizin Berlin

External person

Marie L. De Bruin

  • Netherlands Cancer Institute
  • University of Copenhagen
  • Utrecht University
  • Medicines Evaluation Board

External person

Kamal Chamoun

  • Karyopharm Therapeutics

External person

Xiwen Ma

  • Karyopharm Therapeutics

External person

Sharon Shacham

  • Karyopharm Therapeutics

External person

John Kuruvilla

  • University Health Network

External person

Augustinus D.G. Krol

  • Leiden University Medical Center - LUMC
  • Erasmus Universiteit Rotterdam

External person

Wolfram Klapper

  • Kiel University

External person

Helen Kaul

  • Universität zu Köln
  • University of Cologne

External person

Marnix L. Lybeert

  • Catharina Hospital

External person

B. Arends

  • VU University Medical Hospital

External person

Michael Kauffman

  • Karyopharm Therapeutics

External person

Sigrid Stroobants

  • European Organisation for Research and Treatment of Cancer Data Center
  • University of Antwerp
  • Antwerp University Hospital
  • KU Leuven
  • Vrije Universiteit Amsterdam

External person

Heiko Schöder

  • Memorial Sloan Kettering Cancer Center

External person

Nicola S Russell

  • Netherlands Cancer Institute

External person

Fred J. Verzijlbergen

  • St. Antonius Ziekenhuis
  • Radboudumc

External person

Hans Joachim Beck

  • Johannes Gutenberg University Mainz

External person

Gerben J.C. Zwezerijnen

  • Vrije Universiteit Amsterdam

External person

Robert J. Baatenburg De Jong

  • Department of Otorhinolaryngology-Head and Neck Surgery
  • Erasmus Universiteit Rotterdam
  • Netherlands Association of Comprehensive Cancer Centres
  • Department of Otolaryngology/Head and Neck Surgery

External person

Judith Dierlamm

  • University Medical Center Hamburg-Eppendorf
  • University of Hamburg

External person

Tom van Meerten

  • University of Groningen

External person

Roel de Weijer

  • Utrecht University

External person

Anke van den Berg

  • University of Groningen

External person

J. Pruim

  • St. Antonius Ziekenhuis
  • University Medical Center Groningen
  • PET Centre University

External person

Marjolein W. M. van der Poel

  • Maastricht University

External person

S. Maclennan

  • University of Aberdeen

External person

Okke de Weerdt

  • St. Antonius Ziekenhuis

External person

Patricia Jansen

  • Elisabeth-Tweesteden Ziekenhuis

External person

Olivier Hermine

  • Université Paris Cité
  • Sorbonne Paris Cité
  • Institut national de la santé et de la recherche médicale
  • Hôpital Necker Enfants Malades
  • IMAGINE Institute

External person

Live Eikenes

  • Norwegian University of Science and Technology

External person

S. F. Barrington

  • King's College London

External person

Christian H. Geisler

  • University of Copenhagen

External person

Rishi Nandoe Tewarie

  • Haaglanden Medisch Centrum

External person

Birgit I. Lissenberg-Witte

  • Vrije Universiteit Amsterdam

External person

Yavuz M Bilgin

  • Department of Internal Medicine, Netherlands

External person

Michael J. Morris

  • Memorial Sloan Kettering Cancer Center

External person

Roel J. de Weijer

  • Utrecht University

External person

Martin H. Dreyling

  • Ludwig Maximilian University of Munich

External person

Gerard Pasterkamp

  • Utrecht University

External person

Katinka M. John

  • Netherlands Cancer Institute

External person

Lonneke van de Poll-Franse

  • Tilburg University
  • Research Department
  • Netherlands Comprehensive Cancer Organisation
  • Netherlands Cancer Institute

External person

Olivier Tournilhac

  • CHU de Clermont-Ferrand

External person

Tamás Györke

  • Semmelweis University

External person

Rene X. Menezes

  • VU University Medical Center

External person

David J. Cutter

  • University of Oxford
  • Churchill Hospital

External person

R.P. Baum

  • University of Maryland

External person

Johanna Ramroth

  • University of Oxford

External person

Annika Seitz

  • University Medical Center Groningen

External person

Jean Richard Saint-Martin

  • Karyopharm Therapeutics

External person

Wendy B.C. Stevens

  • Radboud University Medical Center
  • University of the Witwatersrand

External person

Sarah Gillessen

  • Universität zu Köln

External person

Nadia Withofs

  • University of Liège

External person

A. Loft

  • University of Copenhagen

External person

Lorenz Trümper

  • University of Goettingen

External person

A.L. Oen

  • Laurentius Hospital

External person

Pim Cuijpers

  • Leuphana University of Lüneburg
  • Vrije Universiteit Amsterdam
  • VU University Medical Centre

External person

Ilse Houtenbos

  • Department of Hematology

External person

Jatin P. Shah

  • Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College
  • Memorial Sloan Kettering Cancer Center
  • Karyopharm Therapeutics

External person

L. Hooft

  • VU Medisch Centrum
  • Vrije Universiteit Amsterdam

External person

Heleen Verschueren

  • Amsterdam UMC
  • Vrije Universiteit Amsterdam

External person

Bastiaan D. Ta

  • Department of Radiotherapy, Maastricht, Netherlands

External person

Henriette W. Berenschot

  • Department of Internal Medicine, Dordrecht, Netherlands

External person

Paul Baas

  • Netherlands Cancer Institute
  • Antoni Van Leeuwenhoek Hospital

External person

Roland T. Ullrich

  • Universität zu Köln

External person

P.M.P. Poortmans

  • Institut Curie
  • Radboud University Nijmegen

External person

Bakhos A. Tannous

  • Department of Neurology
  • Harvard University

External person

René Otten

  • VU University
  • Vrije Universiteit Amsterdam

External person

Floriske G. Stedema

  • University of Groningen

External person

Lisanne S. Rigter

  • Netherlands Cancer Institute

External person

Philip M. P. Poortmans

  • Radboud University Nijmegen

External person

Huub H. van Rossum

  • Netherlands Cancer Institute

External person

Lidwine W Tick

  • Maxima Medical Centre

External person

Thomas Beyer

  • Medical University of Vienna

External person

Danielle Hoogmoed

  • Leica Biosystems

External person

Pierre Feugier

  • CHU de Nancy

External person

Marianne C. Aznar

  • University of Manchester

External person

Olivier Casasnovas

  • Hématologie Clinique

External person

Andreas Neubauer

  • Universitätsklinikum Giessen und Marburg, Standort Marburg

External person

Matthijs Westerman

  • Department of Hematology

External person

B. de Keizer

  • Princess Máxima Center for Pediatric Oncology
  • Utrecht University

External person

Ulrich Mey

  • Cantonal Hospital

External person

Bernard Verbeeten

  • Vrije Universiteit Amsterdam

External person

Julia E Huijbregts

  • Gelre Ziekenhuizen

External person

Susan K. Lutgendorf

  • University of Iowa

External person

Mark F. Durian

  • Elisabeth-Tweesteden Ziekenhuis

External person

Hanneke C. Kluin-Nelemans

  • University of Groningen
  • Leiden University
  • Dept. Hematol., (R.E.B., M.v.d.H.

External person

Andres Kaalep

  • North Estonia Medical Centre Foundation

External person

Heiddis B. Valdimarsdottir

  • Icahn School of Medicine at Mount Sinai

External person

Berlinda J. de Wit-van der Veen

  • Netherlands Cancer Institute

External person

Marc G. Stevenson

  • University Medical Center Groningen

External person

Pieternella J Lugtenburg

  • Erasmus Universiteit Rotterdam

External person

G. Esther A. Habers

  • Leiden University

External person

Judith M. Roesink

  • Utrecht University

External person

E. Lugtenburg

  • Erasmus Universiteit Rotterdam

External person

Robert Chrzan

  • 1st Department of Cardiology, Interventional Electrocardiology and Hypertension, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland

External person

Sonia Ancoli-israel

  • University of California at San Diego

External person

Emma E. Geerdes

  • cDepartment of Research and Development, Comprehensive Netherlands Cancer Organization, Utrecht, The Netherlands

External person

Harm van Tinteren

  • Netherlands Association of Comprehensive Cancer Centres
  • Erasmus Universiteit Rotterdam

External person

Rineke B. L. Leys

  • Department of Internal Medicine and Infectious Diseases, Maasstad Ziekenhuis, Rotterdam, Netherlands

External person

Sander Roberti

  • Netherlands Cancer Institute

External person

Georgios Ntentas

  • University of Oxford
  • Guy’s Hospital
  • King's College London

External person

Foppe Oldenburger

  • University of Amsterdam

External person

Marek Trneny

  • Charles University

External person

F. Krasniqi

  • University of Basel
  • Swiss Group for Clinical Cancer Research and Cantonal Hospital Lucerne

External person

Hervé Tilly

  • Centre Georges-François Leclerc

External person

Mithat Gonen

  • Memorial Sloan Kettering Cancer Center

External person

Laura Meulenbroeks

  • Amsterdam UMC - University of Amsterdam

External person

A. D.G.Stijn Krol

  • Leiden University

External person

Jenny Xu

  • Karyopharm Therapeutics

External person

Wim J Sluiter

  • University of Groningen

External person

Ruth Scheuvens

  • University of Cologne

External person

Gustaaf W van Imhoff

  • University of Groningen

External person

Bettina Altmann

  • Leipzig University

External person

Grard A.P. Nieuwenhuijzen

  • Catharina Hospital

External person

Daniel McCarthy

  • Karyopharm Therapeutics

External person

Elena Zamagni

  • Università di Bologna
  • Unità Operativa Malattie Infettive

External person

Elisabeth G. E. de Vries

  • University Medical Center Groningen
  • University of Groningen

External person

Jimmie Honings

  • Radboud University Nijmegen Medical Center
  • Radboud University Nijmegen

External person

Annelies Manenschijn

  • Department of Medical Oncology

External person

Yosef Landesman

  • Karyopharm Therapeutics

External person